Serum concentrations of A1AT (or SERPINA1) are assessed clinically,primarily to discover individuals with severe A1AT deficiency.26 It is known that serum concentrations of A1ATcan be influenced by genetics. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.